Clinics ()

Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?

  • Fabio Vieira Teixeira,
  • Rogerio Serafim Parra,
  • Omar Feres,
  • Paulo Gustavo Kotze

DOI
https://doi.org/10.6061/clinics/2019/e1424
Journal volume & issue
Vol. 74

Abstract

Read online

No abstracts available.